GENOMICS PROFILE

EstroGenomic Profile

The EstroGenomic® test uncovers potential genetic susceptibility to diseases and conditions such as:

•Breast cancer

•Osteoporosis

•Thrombosis

•Strokes

•Atherosclerosis

•Heart Disease

Estrogen Metabolism

•CYP1A1

•GST (M1 and P1)

•CYP1B1

•COMT (catechol-O-methyl transferase)

HyperCoagulation

•GP3a (Glycoprotein 3)

•Factor 2 (Prothrombin)

•PAI-1 (Plasminogen activator inhibitor-1)

•Factor 5 (Leiden).

Cardiovascular

•Apo E (apoliprotein E)

•TNF-a

•MTHFR

•IL-6.

Osteoporosis

•VDR

•TNF-a

•IL-6

DetoxiGenomic® Profile evaluates single nucleotide polymorphisms (SNPs) associated with increased risk of impaired detoxification capacity especially when exposed to environmental toxins. It also identifies individuals potentially susceptible to adverse drug reactions.

Phase I: Cytochrome P-450 • CYP1A1 • CYP2A6 • CYP2C9 • CYP3A4 • CYP1B1 • CYP2D6 • CYP1C19

 Phase II: • COMT

Acetylation  (N-acetyl transferase) • NAT1 • NAT2 NAT • GSTM1 • GSTT1 • GSTP1 GST

 • SOD1 • SOD2